Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Avamys 27.5micrograms/dose nasal spray
1202010W0BBAAAA
|
Avamys | Fluticasone furoate | Ear, Nose and Oropharynx | 218,403 |
|
Fluticasone furoate 27.5micrograms/dose nasal spray
1202010W0AAAAAA
|
Fluticasone furoate | Fluticasone furoate | Ear, Nose and Oropharynx | 208,390 |
|
Coryen 27.5micrograms/dose nasal spray
1202010W0BCAAAA
|
Coryen | Fluticasone furoate | Ear, Nose and Oropharynx | 127 |
|
Flutikaz 27.5micrograms/dose nasal spray
1202010W0BDAAAA
|
Flutikaz | Fluticasone furoate | Ear, Nose and Oropharynx | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.